FedericoViganegoMD

PubMed

• 8 citations
  Association between ibrutinib treatment and hypertension.
  Dae Hyun Lee, Fahad Hawk, Kieun Seok, Matthew Gliksman, Josephine Emole, Isaac B Rhea, Federico Viganego, Allan Welter-Frost, Bijal D. Shah, Juliio C Chavez, Javier Pi...> ;Heart. 2021 Jul 1
• 3 citations
  Impact of Global Budget Payments on Cardiovascular Care in Maryland: An Interrupted Time Series Analysis
  Federico Viganego, Eun K. Um, Jasmine Ruffin, Michael G. Fradley, Xavier Prida, Rocco Friebel> ;Circulation. Cardiovascular Quality and Outcomes. 2021 Feb 24
• 6 citations
  Electrocardiographic Changes Associated With Ibrutinib Exposure
  Michael G. Fradley, Allan Welter-Frost, Matthew Gliksman, Josephine Emole, Federico Viganego, Dae Hyun Lee, Bijal D. Shah, Julio C. Chavez, Javier Pinilla-Ibarz, Matth...> ;Cancer Control. 2020 Jun 4
• 37 citations
  Rates and Risk of Atrial Arrhythmias in Patients Treated With Ibrutinib Compared With Cytotoxic Chemotherapy.
  Michael G. Fradley, Matthew Gliksman, Josephine Emole, Federico Viganego, Isaac Rhea, Allan Welter-Frost, Dae Hyun Lee, Christine M. Walko, Bijal D. Shah, Julio C. Cha...> ;The American Journal of Cardiology. 2019 Aug 15
• 17 citations
  Rates and risk of arrhythmias in cancer survivors with chemotherapy-induced cardiomyopathy compared with patients with other cardiomyopathies
  Michael G. Fradley, Federico Viganego, Kevin E. Kip, Angel Martin, Aarti Patel, Roohi Ismail-Khan, Sanders H. Chae, Bengt Herweg, Arthur J. Labovitz> ;Open Heart. 2017 Dec 1
• 41 citations
  Developing a Comprehensive Cardio-Oncology Program at a Cancer Institute: The Moffitt Cancer Center Experience.
  Michael G. Fradley, Allen Brown, Bernadette Shields, Federico Viganego, Rongras Damrongwatanasuk, Aarti Patel, Gregory Hartlage, Natalee Roper, Julie Jaunese, Larry Ro...> ;Oncology Reviews. 2017 Jul 18
• 27 citations
  Arrhythmias and Other Electrophysiology Issues in Cancer Patients Receiving Chemotherapy or Radiation.
  Federico Viganego, Robin Singh, Michael G. Fradley> ;Current Cardiology Reports. 2016 Apr 23
• 30 citations
  Anti-VEGF-Induced Hypertension: a Review of Pathophysiology and Treatment Options.
  Bryan J. Brinda, Federico Viganego, Teresa Vo, Dawn Dolan, Michael G. Fradley> ;Current Treatment Options in Cardiovascular Medicine. 2016 Mar 2
• 8 citations
  Endovascular recanalization of central venous access to allow for pacemaker implantation or upgrade.
  Gabriel Maluenda, Francis Bustos, Federico Viganego, Itsik Ben-Dor, Nicholas N. Hanna, Rebecca Torguson, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto...> ;Cardiovascular Revascularization Medicine. 2012 Jul 1
• 74 citations
  Effect of Early Diagnosis and Treatment With Percutaneous Lead Extraction on Survival in Patients With Cardiac Device Infections
  Federico Viganego, Susan O'Donoghue, Zayd Eldadah, Manish H. Shah, Mohit Rastogi, Jay A. Mazel, Edward V. Platia> ;The American Journal of Cardiology. 2012 May 15
• 182 citations
  High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot st...
  Richard A. Nash, Peter A. McSweeney, Leslie J. Crofford, Muneer H. Abidi, Chien-Shing Chen, J. David Godwin, Ted Gooley, Leona Holmberg, Gretchen Henstorf, C. Fred LeM...> ;Blood. 2007 Aug 15
• 7 citations
  Staphylococcus lugdunensis endocarditis following lower extremity revascularization
  Federico Viganego, Talat M. Nazir, Ching Y. Lee, Jean-Paul Hafner, Raymond P. Smith> ;International Journal of Cardiology. 2007 Mar 2
• 40 citations
  Factors affecting antibody levels after allogeneic hematopoietic cell transplantation.
  Jan Storek, Federico Viganego, Monja A. Dawson, M. M. P. Tineke Herremans, Michael Boeckh, Mary E.D. Flowers, Barry E. Storer, William I. Bensinger, Robert P. Withersp...> ;Blood. 2003 Apr 15
• 5 citations
  Bone marrow transplantation in the treatment of systemic sclerosis
  Federico Viganego, Richard A. Nash, Daniel E. Furst> ;Current Rheumatology Reports. 2000 Dec 1
• Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation.
  Storek, J., Dawson, M. A., Lim, L. C., Burman, B. E., Stevens-Ayers, T., Viganego, F., Herremans, M. M., Flowers, M. E., Witherspoon, R. P., Maloney, D. G., Boeckh, M.> ;Bone Marrow Transplant. 2004 Feb
• Left-sided heart valve abnormalities and risk of ischemic cerebrovascular accidents in patients with systemic lupus erythematosus.
  Morelli, S., Bernardo, M. L., Viganego, F., Sgreccia, A., De Marzio, P., Conti, F., Priori, R., Valesini, G.> ;Lupus. 2003
• 3 citations
  Progression and management of chronic heart failure.
  F. Viganego, T H Le Jemtel> ;Panminerva Medica. 2007 Sep 1
• Antiarrhythmic drug therapy vs catheter ablation for paroxysmal atrial fibrillation.
  Viganego, F.> ;JAMA. 2010 May 12
• Orbital myositis in a patient with primary biliary cirrhosis: successful treatment with methotrexate and corticosteroids.
  Magrini, L., Rotiroti, G., Conti, F., Viganego, F., Alessandri, C., Picardo, V., Valesini, G.> ;Isr Med Assoc J. 2003 Nov
• Anti-carbonic anhydrase II antibodies in systemic sclerosis: association with lung involvement.
  Alessandri, C., Bombardieri, M., Scrivo, R., Viganego, F., Conti, F., de Luca, N., Riccieri, V., Valesini, G.> ;Autoimmunity. 2003 Mar
• Join now to see all